ConferenceThe AMR Conference 2027 is a two-day international meeting focused on innovation in novel antimicrobials and diagnostics for antimicrobial resistance. Organised by the BEAM Alliance and bamconn GmbH, the conference brings together participants from biotechnology and pharmaceutical companies, SMEs and start-ups, academia, hospitals, finance, policy and public institutions.
The programme addresses the development of new antimicrobial treatments and diagnostic technologies, from scientific discovery and preclinical research to clinical development and market strategy. It also covers R&D funding, incentives and investment, with particular attention to the practical challenges involved in bringing new products to patients and healthcare systems.
The conference is particularly relevant to researchers, product developers, industry representatives, investors and policy stakeholders working across the antimicrobial innovation ecosystem.